• Mashup Score: 0

    SARS-CoV-2 antibody levels associated with reduced hospitalization risk remain undefined. Our outpatient COVID-19 convalescent plasma (CCP), placebo-controlled trial observed SARS-CoV-2 antibody levels decreasing 22-fold from matched donor units into post-transfusion seronegative recipients. Unvaccinated recipients were jointly stratified by a) early or late transfusion (≤ 5 or >5 days from…

    Tweet Tweets with this article
    • #Antibody Correlates of #Protection for #COVID19 Convalescent #Plasma Associated with Reduced #Outpatient #Hospitalizations https://t.co/Tv9YNOKBoL https://t.co/6F6E6XYqkB

  • Mashup Score: 0

    A 2011 FDA mandate, which limited acetaminophen dosage to 325 mg/tablet in prescription acetaminophen and opioid products, correlated with a decrease in yearly hospitalizations and cases of acute liver failure related to toxicity.“Anecdotally we had several patients in rapid succession with acetaminophen overdose — in the setting of taking over-the-counter flu/cold medications —

    Tweet Tweets with this article
    • A 2011 @US_FDA mandate, which limited acetaminophen dosage to 325 mg/tablet in prescription #acetaminophen and #opioid products, correlated with a decrease in yearly #hospitalizations and cases of acute #liverfailure related to toxicity. @JAMANetworkOpen https://t.co/bHCsCq6FUm

  • Mashup Score: 0

    NASHVILLE, Tenn. — Initiation of oral selexipag within 12 months of pulmonary arterial hypertension diagnosis may reduce all-cause hospitalizations and overall medical costs, according to a new analysis.“One of the key take-home findings is that earlier initiation of PAH combination therapy can deliver improvement in outcomes, particularly reduction in all-cause

    Tweet Tweets with this article
    • Presented at #CHEST2022: Initiation of #selexipag within 12 months of pulmonary artery hypertension diagnosis may reduce #hospitalizations and medical costs, according to a new analysis @Journal_CHEST #PAH https://t.co/MMbDg4onYX

  • Mashup Score: 0

    SAN DIEGO — Vedolizumab and ustekinumab associated with a lower risk for infection-related hospitalizations compared with anti-tumor necrosis factor agents in patients who initiated inflammatory bowel disease therapy at an older age. “It used to be thought that IBD becomes a milder disease with age and, therefore, there never was a tremendous investment in better understanding modern

    Tweet Tweets with this article
    • #Vedolizumab and #ustekinumab associated with a lower risk for infection-related #hospitalizations compared with anti-tumor necrosis factor agents in patients who initiated #IBD therapy at an older age @bkocharmd @DDWMeeting #DDW2022 #GITwitter https://t.co/jDOWw1Mmag

  • Mashup Score: 0

    SAN DIEGO — Baseline magnetic resonance index of activity score independently predicted the longer-term need for surgery, rescue corticosteroids or hospitalizations among patients with Crohn’s disease. “Multiple methods have been developed to predict outcomes in Crohn’s disease. … The magnetic resonance index of activity, or MaRIA score, is used to quantify disease severity,

    Tweet Tweets with this article
    • Live from #DDW2022: Baseline magnetic resonance index of activity score independently predicted the longer-term need for #surgery, rescue #corticosteroids or #hospitalizations among patients with #Crohns @DDWMeeting @AlvinTGeorgeMD #GITwitter #IBD https://t.co/fyS8TNNUXZ